

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 7.38454292 |
| 2 | maintenance of protein location in nucleus (GO:0051457) | 6.80568375 |
| 3 | somite rostral/caudal axis specification (GO:0032525) | 6.64597061 |
| 4 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 6.50065751 |
| 5 | protein localization to kinetochore (GO:0034501) | 6.39039662 |
| 6 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 6.38336628 |
| 7 | negative regulation of epidermis development (GO:0045683) | 6.28383054 |
| 8 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 6.16393366 |
| 9 | regulation of telomere maintenance via telomerase (GO:0032210) | 6.11409782 |
| 10 | regulation of response to osmotic stress (GO:0047484) | 5.84585038 |
| 11 | negative regulation of telomerase activity (GO:0051974) | 5.80712349 |
| 12 | histone H4-K8 acetylation (GO:0043982) | 5.78981909 |
| 13 | histone H4-K5 acetylation (GO:0043981) | 5.78981909 |
| 14 | proteasome assembly (GO:0043248) | 5.77828381 |
| 15 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 5.73781160 |
| 16 | histone H4-K12 acetylation (GO:0043983) | 5.65692260 |
| 17 | regulation of MHC class I biosynthetic process (GO:0045343) | 5.63554849 |
| 18 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 5.55293088 |
| 19 | rRNA transcription (GO:0009303) | 5.53227730 |
| 20 | muscle organ morphogenesis (GO:0048644) | 5.46345233 |
| 21 | mitotic sister chromatid segregation (GO:0000070) | 5.15376819 |
| 22 | notochord development (GO:0030903) | 5.00024016 |
| 23 | cytidine deamination (GO:0009972) | 4.87890247 |
| 24 | cytidine metabolic process (GO:0046087) | 4.87890247 |
| 25 | cytidine catabolic process (GO:0006216) | 4.87890247 |
| 26 | negative regulation of epidermal cell differentiation (GO:0045605) | 4.86354238 |
| 27 | interferon-gamma production (GO:0032609) | 4.80724270 |
| 28 | negative regulation of telomere maintenance (GO:0032205) | 4.74029499 |
| 29 | heterochromatin organization (GO:0070828) | 4.73423661 |
| 30 | rRNA methylation (GO:0031167) | 4.72421505 |
| 31 | protein localization to chromosome, centromeric region (GO:0071459) | 4.69047214 |
| 32 | regulation of cilium movement (GO:0003352) | 4.65681205 |
| 33 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 4.63783575 |
| 34 | hormone catabolic process (GO:0042447) | 4.61649953 |
| 35 | phenol-containing compound catabolic process (GO:0019336) | 4.54687962 |
| 36 | coenzyme catabolic process (GO:0009109) | 4.48612981 |
| 37 | nucleoside transmembrane transport (GO:1901642) | 4.34437738 |
| 38 | quinone metabolic process (GO:1901661) | 4.32445248 |
| 39 | response to dietary excess (GO:0002021) | 4.28636847 |
| 40 | regulation of translation in response to stress (GO:0043555) | 4.28172577 |
| 41 | histone H4-K16 acetylation (GO:0043984) | 4.27315319 |
| 42 | sister chromatid segregation (GO:0000819) | 4.24212491 |
| 43 | nuclear pore complex assembly (GO:0051292) | 4.23052389 |
| 44 | DNA replication-dependent nucleosome assembly (GO:0006335) | 4.21830043 |
| 45 | DNA replication-dependent nucleosome organization (GO:0034723) | 4.21830043 |
| 46 | rRNA modification (GO:0000154) | 4.18947313 |
| 47 | acrosome reaction (GO:0007340) | 4.18385089 |
| 48 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 4.13116467 |
| 49 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.12241821 |
| 50 | chromatin assembly (GO:0031497) | 4.11846975 |
| 51 | primitive streak formation (GO:0090009) | 4.11519710 |
| 52 | DNA replication checkpoint (GO:0000076) | 4.04447924 |
| 53 | positive regulation of mitochondrial fission (GO:0090141) | 3.90389169 |
| 54 | microtubule severing (GO:0051013) | 3.88259027 |
| 55 | maintenance of protein localization in organelle (GO:0072595) | 3.83764069 |
| 56 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.76095471 |
| 57 | cellular modified amino acid catabolic process (GO:0042219) | 3.74689080 |
| 58 | nuclear pore organization (GO:0006999) | 3.72292666 |
| 59 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 3.71944825 |
| 60 | metallo-sulfur cluster assembly (GO:0031163) | 3.71430604 |
| 61 | iron-sulfur cluster assembly (GO:0016226) | 3.71430604 |
| 62 | protein polyglutamylation (GO:0018095) | 3.70453107 |
| 63 | mitochondrion distribution (GO:0048311) | 3.69256641 |
| 64 | ubiquinone biosynthetic process (GO:0006744) | 3.67443156 |
| 65 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.67184591 |
| 66 | piRNA metabolic process (GO:0034587) | 3.65500531 |
| 67 | regulation of telomere maintenance (GO:0032204) | 3.65433060 |
| 68 | binding of sperm to zona pellucida (GO:0007339) | 3.65168398 |
| 69 | positive regulation of protein deacetylation (GO:0090312) | 3.63738095 |
| 70 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.62067352 |
| 71 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 3.60497729 |
| 72 | sperm-egg recognition (GO:0035036) | 3.56773171 |
| 73 | cardiovascular system development (GO:0072358) | 3.55526182 |
| 74 | cullin deneddylation (GO:0010388) | 3.54389460 |
| 75 | male meiosis I (GO:0007141) | 3.51280477 |
| 76 | sperm motility (GO:0030317) | 3.48550519 |
| 77 | GDP-mannose metabolic process (GO:0019673) | 3.47948279 |
| 78 | tachykinin receptor signaling pathway (GO:0007217) | 3.46730064 |
| 79 | ubiquinone metabolic process (GO:0006743) | 3.45942078 |
| 80 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.45399916 |
| 81 | retinoic acid receptor signaling pathway (GO:0048384) | 3.45201875 |
| 82 | regulation of telomerase activity (GO:0051972) | 3.45005180 |
| 83 | pre-miRNA processing (GO:0031054) | 3.44724732 |
| 84 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.43415934 |
| 85 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.43415934 |
| 86 | regulation of mitochondrial translation (GO:0070129) | 3.42971318 |
| 87 | galactose catabolic process (GO:0019388) | 3.42071444 |
| 88 | bone trabecula formation (GO:0060346) | 3.39797744 |
| 89 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.39200240 |
| 90 | histone H2A acetylation (GO:0043968) | 3.38485493 |
| 91 | single strand break repair (GO:0000012) | 3.36424014 |
| 92 | intestinal epithelial cell development (GO:0060576) | 3.36376078 |
| 93 | epoxygenase P450 pathway (GO:0019373) | 3.36152166 |
| 94 | mRNA stabilization (GO:0048255) | 3.32769925 |
| 95 | RNA stabilization (GO:0043489) | 3.32769925 |
| 96 | response to pheromone (GO:0019236) | 3.32387773 |
| 97 | protein deneddylation (GO:0000338) | 3.28879840 |
| 98 | establishment of viral latency (GO:0019043) | 3.27048918 |
| 99 | positive regulation of histone deacetylation (GO:0031065) | 3.26685682 |
| 100 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 3.26549151 |
| 101 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 3.26441868 |
| 102 | transcription from mitochondrial promoter (GO:0006390) | 3.24371329 |
| 103 | L-serine metabolic process (GO:0006563) | 3.22387997 |
| 104 | nucleoside transport (GO:0015858) | 3.21623724 |
| 105 | signal transduction involved in regulation of gene expression (GO:0023019) | 3.19641978 |
| 106 | DNA methylation involved in gamete generation (GO:0043046) | 3.19231789 |
| 107 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.17590485 |
| 108 | spermatid development (GO:0007286) | 3.16444092 |
| 109 | proline transport (GO:0015824) | 3.16110456 |
| 110 | pore complex assembly (GO:0046931) | 3.15559155 |
| 111 | vitamin A metabolic process (GO:0006776) | 3.15283987 |
| 112 | meiosis I (GO:0007127) | 3.12986188 |
| 113 | lipopolysaccharide metabolic process (GO:0008653) | 3.12707946 |
| 114 | ribosome biogenesis (GO:0042254) | 3.12707783 |
| 115 | icosanoid secretion (GO:0032309) | 3.11569877 |
| 116 | arachidonic acid secretion (GO:0050482) | 3.11569877 |
| 117 | mitotic chromosome condensation (GO:0007076) | 3.10470182 |
| 118 | microtubule depolymerization (GO:0007019) | 3.08779680 |
| 119 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.08324780 |
| 120 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.07368153 |
| 121 | DNA duplex unwinding (GO:0032508) | 3.05725391 |
| 122 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.05697820 |
| 123 | DNA geometric change (GO:0032392) | 3.02461809 |
| 124 | cofactor transport (GO:0051181) | 3.02148783 |
| 125 | omega-hydroxylase P450 pathway (GO:0097267) | 3.00946923 |
| 126 | maternal placenta development (GO:0001893) | 3.00005935 |
| 127 | tRNA aminoacylation for protein translation (GO:0006418) | 2.99117520 |
| 128 | base-excision repair, AP site formation (GO:0006285) | 2.98951255 |
| 129 | regulation of microtubule-based movement (GO:0060632) | 2.98233870 |
| 130 | mitochondrial fission (GO:0000266) | 2.98204478 |
| 131 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.98002263 |
| 132 | apoptotic DNA fragmentation (GO:0006309) | 2.96295652 |
| 133 | trophectodermal cell differentiation (GO:0001829) | 2.96294848 |
| 134 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.94676086 |
| 135 | plasma membrane fusion (GO:0045026) | 2.93599876 |
| 136 | negative regulation of ligase activity (GO:0051352) | 2.92883053 |
| 137 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.92883053 |
| 138 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.89337530 |
| 139 | cellular biogenic amine biosynthetic process (GO:0042401) | 2.88402907 |
| 140 | protein complex biogenesis (GO:0070271) | 2.88319385 |
| 141 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.87506850 |
| 142 | adaptation of signaling pathway (GO:0023058) | 2.86311758 |
| 143 | microtubule polymerization or depolymerization (GO:0031109) | 2.83298990 |
| 144 | regulation of mitochondrial fission (GO:0090140) | 2.83023231 |
| 145 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.82123411 |
| 146 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.81812100 |
| 147 | resolution of meiotic recombination intermediates (GO:0000712) | 2.80765489 |
| 148 | type B pancreatic cell proliferation (GO:0044342) | 2.80695970 |
| 149 | amino acid activation (GO:0043038) | 2.80441347 |
| 150 | tRNA aminoacylation (GO:0043039) | 2.80441347 |
| 151 | amine biosynthetic process (GO:0009309) | 2.77938653 |
| 152 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.77664097 |
| 153 | spermatid nucleus differentiation (GO:0007289) | 2.76472795 |
| 154 | ribosome assembly (GO:0042255) | 2.76208755 |
| 155 | multicellular organism reproduction (GO:0032504) | 2.75899597 |
| 156 | peroxisome fission (GO:0016559) | 2.75166105 |
| 157 | quinone biosynthetic process (GO:1901663) | 2.74777686 |
| 158 | branched-chain amino acid catabolic process (GO:0009083) | 2.74344336 |
| 159 | protein targeting to mitochondrion (GO:0006626) | 2.73576227 |
| 160 | establishment of integrated proviral latency (GO:0075713) | 2.72694654 |
| 161 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.72164336 |
| 162 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.72164336 |
| 163 | protein localization to mitochondrion (GO:0070585) | 2.71764161 |
| 164 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.70692154 |
| 165 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.70692154 |
| 166 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.70692154 |
| 167 | peptidyl-histidine modification (GO:0018202) | 2.70286892 |
| 168 | chaperone-mediated protein transport (GO:0072321) | 2.70182800 |
| 169 | intraciliary transport (GO:0042073) | 2.68525731 |
| 170 | cell-cell recognition (GO:0009988) | 2.67625629 |
| 171 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.67544742 |
| 172 | protein-cofactor linkage (GO:0018065) | 2.66549024 |
| 173 | nonmotile primary cilium assembly (GO:0035058) | 2.66486872 |
| 174 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.65915402 |
| 175 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.64879247 |
| 176 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.64234152 |
| 177 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.64051485 |
| 178 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.64051485 |
| 179 | ncRNA 3-end processing (GO:0043628) | 2.63933577 |
| 180 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.62625941 |
| 181 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.61585387 |
| 182 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.61585387 |
| 183 | platelet dense granule organization (GO:0060155) | 2.61354626 |
| 184 | positive regulation of ligase activity (GO:0051351) | 2.60894051 |
| 185 | regulation of centriole replication (GO:0046599) | 2.58700686 |
| 186 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.58518856 |
| 187 | tRNA methylation (GO:0030488) | 2.57855946 |
| 188 | C-terminal protein lipidation (GO:0006501) | 2.57553370 |
| 189 | mannosylation (GO:0097502) | 2.57530307 |
| 190 | polyketide metabolic process (GO:0030638) | 11.5219406 |
| 191 | doxorubicin metabolic process (GO:0044598) | 11.5219406 |
| 192 | daunorubicin metabolic process (GO:0044597) | 11.5219406 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.75786949 |
| 2 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 6.56455043 |
| 3 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 6.56455043 |
| 4 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 6.56455043 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.66116803 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.40164650 |
| 7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 4.01665787 |
| 8 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.96689703 |
| 9 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 3.50282316 |
| 10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.27365020 |
| 11 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 3.25009757 |
| 12 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 3.03845911 |
| 13 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.89717251 |
| 14 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.84701353 |
| 15 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.83066841 |
| 16 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.73651286 |
| 17 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.72302970 |
| 18 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.60448396 |
| 19 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.58940778 |
| 20 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.50149597 |
| 21 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.48070056 |
| 22 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.42647490 |
| 23 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.39497775 |
| 24 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.37065968 |
| 25 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.36793254 |
| 26 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.32646920 |
| 27 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.30355380 |
| 28 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.25652496 |
| 29 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.25072772 |
| 30 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.21840137 |
| 31 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.21097068 |
| 32 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 2.07214679 |
| 33 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.06945138 |
| 34 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.00473305 |
| 35 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.99052002 |
| 36 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.96540138 |
| 37 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.95915008 |
| 38 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.94014926 |
| 39 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.88237430 |
| 40 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.82682556 |
| 41 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.82089931 |
| 42 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.81038296 |
| 43 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.79578049 |
| 44 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.78691559 |
| 45 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.76717974 |
| 46 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.75000706 |
| 47 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.69397595 |
| 48 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.69231895 |
| 49 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.68892621 |
| 50 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.63471485 |
| 51 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.63466738 |
| 52 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.63027873 |
| 53 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.62954790 |
| 54 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.57530263 |
| 55 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.56419122 |
| 56 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.54542781 |
| 57 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.52861317 |
| 58 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.50174720 |
| 59 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.47256235 |
| 60 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.46758325 |
| 61 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.46110208 |
| 62 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.41929701 |
| 63 | MYC_22102868_ChIP-Seq_BL_Human | 1.41904606 |
| 64 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.41718900 |
| 65 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.40017040 |
| 66 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.38991280 |
| 67 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.38604462 |
| 68 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.38316361 |
| 69 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.38100749 |
| 70 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.38047511 |
| 71 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.36232598 |
| 72 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.35529471 |
| 73 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.34793230 |
| 74 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.31394193 |
| 75 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.30695005 |
| 76 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.30285798 |
| 77 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.29543447 |
| 78 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.28543246 |
| 79 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.28456858 |
| 80 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.27742696 |
| 81 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.27650954 |
| 82 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.27395062 |
| 83 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.27136889 |
| 84 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.26918191 |
| 85 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.24579315 |
| 86 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.23560848 |
| 87 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.22590954 |
| 88 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.22115768 |
| 89 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.18867763 |
| 90 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.18110151 |
| 91 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.16714613 |
| 92 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.12406571 |
| 93 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.11863723 |
| 94 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.10250757 |
| 95 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.08009449 |
| 96 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.07210373 |
| 97 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.06916396 |
| 98 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.06572498 |
| 99 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.06399874 |
| 100 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.04814402 |
| 101 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04130135 |
| 102 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.02388798 |
| 103 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.00029932 |
| 104 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.99862292 |
| 105 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.99226222 |
| 106 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.98521552 |
| 107 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.98173963 |
| 108 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.96986635 |
| 109 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.96878130 |
| 110 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.96023526 |
| 111 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.94845648 |
| 112 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.92961138 |
| 113 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.91770647 |
| 114 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.91513097 |
| 115 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.91247471 |
| 116 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.91029228 |
| 117 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.89750394 |
| 118 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.89732998 |
| 119 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.87725484 |
| 120 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87223712 |
| 121 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.86268114 |
| 122 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.85551792 |
| 123 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.85357023 |
| 124 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.85107961 |
| 125 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.84958347 |
| 126 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.84914641 |
| 127 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.84346851 |
| 128 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.84324485 |
| 129 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.84192693 |
| 130 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.84102729 |
| 131 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.84101728 |
| 132 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.84084682 |
| 133 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.83948275 |
| 134 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.83471553 |
| 135 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.82981740 |
| 136 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.80607415 |
| 137 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.80122003 |
| 138 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79589516 |
| 139 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.78683549 |
| 140 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.78073080 |
| 141 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.78000115 |
| 142 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.77908875 |
| 143 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.77532326 |
| 144 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.75708799 |
| 145 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.73798042 |
| 146 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.73705283 |
| 147 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.73403168 |
| 148 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.73188177 |
| 149 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.72740448 |
| 150 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.72419002 |
| 151 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.72295941 |
| 152 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.71922826 |
| 153 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.71922826 |
| 154 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.71618399 |
| 155 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.71510869 |
| 156 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.70909736 |
| 157 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.70900139 |
| 158 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.70878731 |
| 159 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.69904853 |
| 160 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.69203218 |
| 161 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.68860576 |
| 162 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.67485347 |
| 163 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.65413674 |
| 164 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.65040854 |
| 165 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.63585653 |
| 166 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.63513008 |
| 167 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.62461250 |
| 168 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.62405852 |
| 169 | P68_20966046_ChIP-Seq_HELA_Human | 0.62138280 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006292_abnormal_olfactory_placode | 4.60294970 |
| 2 | MP0003011_delayed_dark_adaptation | 4.53984016 |
| 3 | MP0004264_abnormal_extraembryonic_tissu | 4.43246201 |
| 4 | MP0002254_reproductive_system_inflammat | 4.07637279 |
| 5 | MP0003718_maternal_effect | 4.01229815 |
| 6 | MP0003890_abnormal_embryonic-extraembry | 3.64514382 |
| 7 | MP0005410_abnormal_fertilization | 3.52875939 |
| 8 | MP0008058_abnormal_DNA_repair | 3.40176581 |
| 9 | MP0005394_taste/olfaction_phenotype | 3.38679128 |
| 10 | MP0005499_abnormal_olfactory_system | 3.38679128 |
| 11 | MP0004858_abnormal_nervous_system | 3.37930596 |
| 12 | MP0003122_maternal_imprinting | 3.35999025 |
| 13 | MP0008057_abnormal_DNA_replication | 3.19406216 |
| 14 | MP0000372_irregular_coat_pigmentation | 3.17667742 |
| 15 | MP0005075_abnormal_melanosome_morpholog | 3.16588787 |
| 16 | MP0002102_abnormal_ear_morphology | 2.93571052 |
| 17 | MP0002332_abnormal_exercise_endurance | 2.72917804 |
| 18 | MP0005257_abnormal_intraocular_pressure | 2.69619661 |
| 19 | MP0008877_abnormal_DNA_methylation | 2.69181891 |
| 20 | MP0004957_abnormal_blastocyst_morpholog | 2.68424741 |
| 21 | MP0003121_genomic_imprinting | 2.66280967 |
| 22 | MP0008260_abnormal_autophagy | 2.57928688 |
| 23 | MP0004233_abnormal_muscle_weight | 2.50229539 |
| 24 | MP0002653_abnormal_ependyma_morphology | 2.49353275 |
| 25 | MP0003186_abnormal_redox_activity | 2.38158508 |
| 26 | MP0002736_abnormal_nociception_after | 2.35145955 |
| 27 | MP0000678_abnormal_parathyroid_gland | 2.35135121 |
| 28 | MP0006035_abnormal_mitochondrial_morpho | 2.32798042 |
| 29 | MP0001929_abnormal_gametogenesis | 2.22473274 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 2.22014545 |
| 31 | MP0001986_abnormal_taste_sensitivity | 2.18837616 |
| 32 | MP0001968_abnormal_touch/_nociception | 2.14584978 |
| 33 | MP0010352_gastrointestinal_tract_polyps | 2.05911462 |
| 34 | MP0009840_abnormal_foam_cell | 2.00258259 |
| 35 | MP0003698_abnormal_male_reproductive | 1.99677523 |
| 36 | MP0003123_paternal_imprinting | 1.92333171 |
| 37 | MP0005380_embryogenesis_phenotype | 1.84116339 |
| 38 | MP0001672_abnormal_embryogenesis/_devel | 1.84116339 |
| 39 | MP0003183_abnormal_peptide_metabolism | 1.82284386 |
| 40 | MP0001905_abnormal_dopamine_level | 1.79264746 |
| 41 | MP0001529_abnormal_vocalization | 1.76097375 |
| 42 | MP0002127_abnormal_cardiovascular_syste | 1.74829239 |
| 43 | MP0002277_abnormal_respiratory_mucosa | 1.71801463 |
| 44 | MP0002088_abnormal_embryonic_growth/wei | 1.70928936 |
| 45 | MP0003938_abnormal_ear_development | 1.69809849 |
| 46 | MP0003984_embryonic_growth_retardation | 1.69231373 |
| 47 | MP0008961_abnormal_basal_metabolism | 1.65355151 |
| 48 | MP0006082_CNS_inflammation | 1.65316262 |
| 49 | MP0002234_abnormal_pharynx_morphology | 1.59870854 |
| 50 | MP0002210_abnormal_sex_determination | 1.59792658 |
| 51 | MP0006036_abnormal_mitochondrial_physio | 1.51080046 |
| 52 | MP0001293_anophthalmia | 1.49871648 |
| 53 | MP0003077_abnormal_cell_cycle | 1.49291081 |
| 54 | MP0002734_abnormal_mechanical_nocicepti | 1.48745266 |
| 55 | MP0002932_abnormal_joint_morphology | 1.47777121 |
| 56 | MP0002161_abnormal_fertility/fecundity | 1.46346874 |
| 57 | MP0000350_abnormal_cell_proliferation | 1.46232671 |
| 58 | MP0010030_abnormal_orbit_morphology | 1.42679600 |
| 59 | MP0003136_yellow_coat_color | 1.42182612 |
| 60 | MP0001849_ear_inflammation | 1.42076789 |
| 61 | MP0005395_other_phenotype | 1.40899132 |
| 62 | MP0002396_abnormal_hematopoietic_system | 1.38609985 |
| 63 | MP0003787_abnormal_imprinting | 1.38510374 |
| 64 | MP0004147_increased_porphyrin_level | 1.38496992 |
| 65 | MP0005248_abnormal_Harderian_gland | 1.32823495 |
| 66 | MP0001984_abnormal_olfaction | 1.32801025 |
| 67 | MP0005451_abnormal_body_composition | 1.31893009 |
| 68 | MP0009697_abnormal_copulation | 1.31817223 |
| 69 | MP0003878_abnormal_ear_physiology | 1.31777409 |
| 70 | MP0005377_hearing/vestibular/ear_phenot | 1.31777409 |
| 71 | MP0003111_abnormal_nucleus_morphology | 1.28195554 |
| 72 | MP0002086_abnormal_extraembryonic_tissu | 1.28177883 |
| 73 | MP0000015_abnormal_ear_pigmentation | 1.27419432 |
| 74 | MP0008789_abnormal_olfactory_epithelium | 1.26757270 |
| 75 | MP0002092_abnormal_eye_morphology | 1.25874423 |
| 76 | MP0005266_abnormal_metabolism | 1.25171771 |
| 77 | MP0002085_abnormal_embryonic_tissue | 1.24674391 |
| 78 | MP0000049_abnormal_middle_ear | 1.22927197 |
| 79 | MP0000653_abnormal_sex_gland | 1.22128511 |
| 80 | MP0010094_abnormal_chromosome_stability | 1.22096661 |
| 81 | MP0001324_abnormal_eye_pigmentation | 1.20593856 |
| 82 | MP0003646_muscle_fatigue | 1.20490269 |
| 83 | MP0000762_abnormal_tongue_morphology | 1.16384353 |
| 84 | MP0004043_abnormal_pH_regulation | 1.14465150 |
| 85 | MP0005253_abnormal_eye_physiology | 1.14153163 |
| 86 | MP0005670_abnormal_white_adipose | 1.13703358 |
| 87 | MP0002735_abnormal_chemical_nociception | 1.13586680 |
| 88 | MP0005647_abnormal_sex_gland | 1.10649840 |
| 89 | MP0001145_abnormal_male_reproductive | 1.10199919 |
| 90 | MP0002114_abnormal_axial_skeleton | 1.10067848 |
| 91 | MP0002970_abnormal_white_adipose | 1.07832984 |
| 92 | MP0005551_abnormal_eye_electrophysiolog | 1.07204549 |
| 93 | MP0003806_abnormal_nucleotide_metabolis | 1.06483224 |
| 94 | MP0002233_abnormal_nose_morphology | 1.05155161 |
| 95 | MP0005171_absent_coat_pigmentation | 1.04185365 |
| 96 | MP0002084_abnormal_developmental_patter | 1.04139335 |
| 97 | MP0003786_premature_aging | 1.03215924 |
| 98 | MP0001348_abnormal_lacrimal_gland | 1.00352434 |
| 99 | MP0001545_abnormal_hematopoietic_system | 1.00134535 |
| 100 | MP0005397_hematopoietic_system_phenotyp | 1.00134535 |
| 101 | MP0008995_early_reproductive_senescence | 0.99255755 |
| 102 | MP0003935_abnormal_craniofacial_develop | 0.96473317 |
| 103 | MP0000432_abnormal_head_morphology | 0.96043455 |
| 104 | MP0000428_abnormal_craniofacial_morphol | 0.95838648 |
| 105 | MP0005423_abnormal_somatic_nervous | 0.95296863 |
| 106 | MP0006276_abnormal_autonomic_nervous | 0.93749576 |
| 107 | MP0008770_decreased_survivor_rate | 0.93575140 |
| 108 | MP0001188_hyperpigmentation | 0.93199993 |
| 109 | MP0003119_abnormal_digestive_system | 0.92729834 |
| 110 | MP0000490_abnormal_crypts_of | 0.92672857 |
| 111 | MP0005408_hypopigmentation | 0.92512474 |
| 112 | MP0000313_abnormal_cell_death | 0.91591588 |
| 113 | MP0002132_abnormal_respiratory_system | 0.91570289 |
| 114 | MP0002229_neurodegeneration | 0.90643971 |
| 115 | MP0003880_abnormal_central_pattern | 0.90109438 |
| 116 | MP0003755_abnormal_palate_morphology | 0.89706902 |
| 117 | MP0003137_abnormal_impulse_conducting | 0.89660826 |
| 118 | MP0004133_heterotaxia | 0.88871819 |
| 119 | MP0003950_abnormal_plasma_membrane | 0.88862306 |
| 120 | MP0004270_analgesia | 0.88708005 |
| 121 | MP0008007_abnormal_cellular_replicative | 0.88514646 |
| 122 | MP0003329_amyloid_beta_deposits | 0.88384860 |
| 123 | MP0003283_abnormal_digestive_organ | 0.88152270 |
| 124 | MP0001764_abnormal_homeostasis | 0.87151555 |
| 125 | MP0004197_abnormal_fetal_growth/weight/ | 0.86225720 |
| 126 | MP0001730_embryonic_growth_arrest | 0.85960052 |
| 127 | MP0005623_abnormal_meninges_morphology | 0.85498328 |
| 128 | MP0005332_abnormal_amino_acid | 0.85193670 |
| 129 | MP0003315_abnormal_perineum_morphology | 0.85097540 |
| 130 | MP0008932_abnormal_embryonic_tissue | 0.84344366 |
| 131 | MP0005391_vision/eye_phenotype | 0.83232907 |
| 132 | MP0001697_abnormal_embryo_size | 0.83166842 |
| 133 | MP0000751_myopathy | 0.81519977 |
| 134 | MP0002269_muscular_atrophy | 0.81418999 |
| 135 | MP0005508_abnormal_skeleton_morphology | 0.79853863 |
| 136 | MP0002177_abnormal_outer_ear | 0.78870416 |
| 137 | MP0002067_abnormal_sensory_capabilities | 0.78246799 |
| 138 | MP0002751_abnormal_autonomic_nervous | 0.78104523 |
| 139 | MP0002925_abnormal_cardiovascular_devel | 0.77749889 |
| 140 | MP0002080_prenatal_lethality | 0.77143266 |
| 141 | MP0004381_abnormal_hair_follicle | 0.76961672 |
| 142 | MP0004145_abnormal_muscle_electrophysio | 0.76730229 |
| 143 | MP0003656_abnormal_erythrocyte_physiolo | 0.75687464 |
| 144 | MP0002116_abnormal_craniofacial_bone | 0.73588338 |
| 145 | MP0000358_abnormal_cell_content/ | 0.71371248 |
| 146 | MP0002733_abnormal_thermal_nociception | 0.71229328 |
| 147 | MP0000749_muscle_degeneration | 0.70443787 |
| 148 | MP0001119_abnormal_female_reproductive | 0.69212408 |
| 149 | MP0003699_abnormal_female_reproductive | 0.69198245 |
| 150 | MP0003221_abnormal_cardiomyocyte_apopto | 0.67839181 |
| 151 | MP0001286_abnormal_eye_development | 0.67144226 |
| 152 | MP0004859_abnormal_synaptic_plasticity | 0.66366615 |
| 153 | MP0000747_muscle_weakness | 0.65778349 |
| 154 | MP0006072_abnormal_retinal_apoptosis | 0.64743187 |
| 155 | MP0002095_abnormal_skin_pigmentation | 0.64678083 |
| 156 | MP0005023_abnormal_wound_healing | 0.64471446 |
| 157 | MP0009703_decreased_birth_body | 0.63915141 |
| 158 | MP0003693_abnormal_embryo_hatching | 0.63882582 |
| 159 | MP0002877_abnormal_melanocyte_morpholog | 0.62727005 |
| 160 | MP0002249_abnormal_larynx_morphology | 0.61025455 |
| 161 | MP0005384_cellular_phenotype | 0.59576215 |
| 162 | MP0004782_abnormal_surfactant_physiolog | 0.56982762 |
| 163 | MP0002081_perinatal_lethality | 0.56965640 |
| 164 | MP0000750_abnormal_muscle_regeneration | 0.55764538 |
| 165 | MP0005310_abnormal_salivary_gland | 0.54221318 |
| 166 | MP0002019_abnormal_tumor_incidence | 0.52849244 |
| 167 | MP0003937_abnormal_limbs/digits/tail_de | 0.52287066 |
| 168 | MP0009115_abnormal_fat_cell | 0.52264432 |
| 169 | MP0001270_distended_abdomen | 0.50707361 |
| 170 | MP0003861_abnormal_nervous_system | 0.49843557 |
| 171 | MP0005319_abnormal_enzyme/_coenzyme | 0.49479533 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral microphthalmos (HP:0007633) | 7.53553338 |
| 2 | Hypochromic microcytic anemia (HP:0004840) | 6.15751388 |
| 3 | Hepatoblastoma (HP:0002884) | 5.93864237 |
| 4 | Abnormality of the lower motor neuron (HP:0002366) | 4.99439602 |
| 5 | Multiple enchondromatosis (HP:0005701) | 4.88615942 |
| 6 | Rib fusion (HP:0000902) | 4.72611433 |
| 7 | Ependymoma (HP:0002888) | 4.63715069 |
| 8 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 4.13189287 |
| 9 | Hypoplasia of the fovea (HP:0007750) | 4.13189287 |
| 10 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.04506864 |
| 11 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.87890983 |
| 12 | Neoplasm of striated muscle (HP:0009728) | 3.77631605 |
| 13 | Rhabdomyosarcoma (HP:0002859) | 3.65361733 |
| 14 | Embryonal renal neoplasm (HP:0011794) | 3.59447088 |
| 15 | Acute necrotizing encephalopathy (HP:0006965) | 3.52563948 |
| 16 | Chromsome breakage (HP:0040012) | 3.49623576 |
| 17 | Hepatocellular necrosis (HP:0001404) | 3.48758320 |
| 18 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.46767601 |
| 19 | Acute encephalopathy (HP:0006846) | 3.45166680 |
| 20 | Hepatic necrosis (HP:0002605) | 3.43549171 |
| 21 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.34823646 |
| 22 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.34823646 |
| 23 | Abnormality of the astrocytes (HP:0100707) | 3.32415604 |
| 24 | Astrocytoma (HP:0009592) | 3.32415604 |
| 25 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.32166140 |
| 26 | Rectovaginal fistula (HP:0000143) | 3.30226739 |
| 27 | Rectal fistula (HP:0100590) | 3.30226739 |
| 28 | Bifid tongue (HP:0010297) | 3.25514534 |
| 29 | Ragged-red muscle fibers (HP:0003200) | 3.20435698 |
| 30 | Abnormality of the fovea (HP:0000493) | 3.20340292 |
| 31 | Generalized aminoaciduria (HP:0002909) | 3.15714917 |
| 32 | Anomalous pulmonary venous return (HP:0010772) | 3.12878576 |
| 33 | Testicular atrophy (HP:0000029) | 3.12422946 |
| 34 | Intestinal fistula (HP:0100819) | 3.06449085 |
| 35 | Cholecystitis (HP:0001082) | 3.00767188 |
| 36 | Abnormal gallbladder physiology (HP:0012438) | 3.00767188 |
| 37 | Increased CSF lactate (HP:0002490) | 3.00406483 |
| 38 | Mitochondrial inheritance (HP:0001427) | 2.99431815 |
| 39 | Fused cervical vertebrae (HP:0002949) | 2.95936589 |
| 40 | Progressive macrocephaly (HP:0004481) | 2.95144682 |
| 41 | Partial duplication of thumb phalanx (HP:0009944) | 2.93595957 |
| 42 | Amyotrophic lateral sclerosis (HP:0007354) | 2.92744066 |
| 43 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.90147385 |
| 44 | Hypoplastic pelvis (HP:0008839) | 2.89889106 |
| 45 | Abnormal lung lobation (HP:0002101) | 2.86238750 |
| 46 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.83545814 |
| 47 | Short humerus (HP:0005792) | 2.82180825 |
| 48 | Vaginal fistula (HP:0004320) | 2.81765727 |
| 49 | Increased serum lactate (HP:0002151) | 2.81654501 |
| 50 | Abnormality of the salivary glands (HP:0010286) | 2.80918410 |
| 51 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.79498417 |
| 52 | Neonatal respiratory distress (HP:0002643) | 2.73691870 |
| 53 | Hypokinesia (HP:0002375) | 2.71931746 |
| 54 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.71376644 |
| 55 | Horizontal nystagmus (HP:0000666) | 2.70213116 |
| 56 | Congenital primary aphakia (HP:0007707) | 2.66097232 |
| 57 | Male infertility (HP:0003251) | 2.65052142 |
| 58 | Increased serum pyruvate (HP:0003542) | 2.65024324 |
| 59 | Hypochromic anemia (HP:0001931) | 2.64397974 |
| 60 | Gait imbalance (HP:0002141) | 2.63389015 |
| 61 | Trismus (HP:0000211) | 2.62218133 |
| 62 | Abnormality of the pulmonary veins (HP:0011718) | 2.62192556 |
| 63 | Type I transferrin isoform profile (HP:0003642) | 2.61890484 |
| 64 | Lactic acidosis (HP:0003128) | 2.61567652 |
| 65 | Meckel diverticulum (HP:0002245) | 2.60603953 |
| 66 | Abnormal cartilage morphology (HP:0002763) | 2.57662237 |
| 67 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.57154906 |
| 68 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.55050982 |
| 69 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.55050982 |
| 70 | Abnormal protein glycosylation (HP:0012346) | 2.55050982 |
| 71 | Abnormal glycosylation (HP:0012345) | 2.55050982 |
| 72 | Periauricular skin pits (HP:0100277) | 2.54719169 |
| 73 | Preauricular pit (HP:0004467) | 2.54719169 |
| 74 | Absent epiphyses (HP:0010577) | 2.54614673 |
| 75 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.54614673 |
| 76 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.54560030 |
| 77 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.54321926 |
| 78 | Nephrogenic diabetes insipidus (HP:0009806) | 2.53465312 |
| 79 | Partial duplication of the phalanx of hand (HP:0009999) | 2.52126515 |
| 80 | Preauricular skin tag (HP:0000384) | 2.51565053 |
| 81 | Cerebral edema (HP:0002181) | 2.49449918 |
| 82 | Retinal dysplasia (HP:0007973) | 2.46477218 |
| 83 | Rhinitis (HP:0012384) | 2.46355876 |
| 84 | Pendular nystagmus (HP:0012043) | 2.43850609 |
| 85 | Abnormality of glycolysis (HP:0004366) | 2.43786954 |
| 86 | Abnormal ciliary motility (HP:0012262) | 2.43387374 |
| 87 | Abnormality of the ileum (HP:0001549) | 2.42358982 |
| 88 | Prolonged neonatal jaundice (HP:0006579) | 2.42131261 |
| 89 | Impulsivity (HP:0100710) | 2.42099224 |
| 90 | Reduced antithrombin III activity (HP:0001976) | 2.42071428 |
| 91 | Glioma (HP:0009733) | 2.41410190 |
| 92 | Shawl scrotum (HP:0000049) | 2.40518663 |
| 93 | Hyperventilation (HP:0002883) | 2.39911613 |
| 94 | Generalized hypotonia (HP:0001290) | 2.39625044 |
| 95 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.37788010 |
| 96 | High anterior hairline (HP:0009890) | 2.37724853 |
| 97 | Rough bone trabeculation (HP:0100670) | 2.32843156 |
| 98 | Hand muscle atrophy (HP:0009130) | 2.32160857 |
| 99 | Severe visual impairment (HP:0001141) | 2.31747694 |
| 100 | Supernumerary spleens (HP:0009799) | 2.31176176 |
| 101 | Tongue fasciculations (HP:0001308) | 2.31136306 |
| 102 | Medial flaring of the eyebrow (HP:0010747) | 2.25335311 |
| 103 | Exercise intolerance (HP:0003546) | 2.25214063 |
| 104 | Nasolacrimal duct obstruction (HP:0000579) | 2.24989680 |
| 105 | Abnormality of chromosome segregation (HP:0002916) | 2.24305763 |
| 106 | Emotional lability (HP:0000712) | 2.24094783 |
| 107 | CNS demyelination (HP:0007305) | 2.23787763 |
| 108 | Type 2 muscle fiber atrophy (HP:0003554) | 2.23565388 |
| 109 | Skin tags (HP:0010609) | 2.22155300 |
| 110 | Large earlobe (HP:0009748) | 2.20672845 |
| 111 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.19903705 |
| 112 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.18566376 |
| 113 | Redundant skin (HP:0001582) | 2.17728173 |
| 114 | Neoplasm of the heart (HP:0100544) | 2.17276971 |
| 115 | Malignant neoplasm of the central nervous system (HP:0100836) | 2.17002200 |
| 116 | Upper limb muscle weakness (HP:0003484) | 2.15765086 |
| 117 | Upper motor neuron abnormality (HP:0002127) | 2.14271855 |
| 118 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.13723860 |
| 119 | Villous atrophy (HP:0011473) | 2.13723860 |
| 120 | Short 5th finger (HP:0009237) | 2.13429087 |
| 121 | Progressive inability to walk (HP:0002505) | 2.12681124 |
| 122 | Opisthotonus (HP:0002179) | 2.11894523 |
| 123 | Aplasia of the musculature (HP:0100854) | 2.11823572 |
| 124 | Delayed gross motor development (HP:0002194) | 2.11703786 |
| 125 | Microretrognathia (HP:0000308) | 2.11139953 |
| 126 | Tetraplegia (HP:0002445) | 2.10840955 |
| 127 | Progressive muscle weakness (HP:0003323) | 2.10585153 |
| 128 | Exercise-induced muscle cramps (HP:0003710) | 2.10581229 |
| 129 | Hypopigmentation of the fundus (HP:0007894) | 2.10342627 |
| 130 | Cheilitis (HP:0100825) | 2.09521350 |
| 131 | Diminished movement (HP:0002374) | 2.09468619 |
| 132 | Abnormality of the pubic bones (HP:0003172) | 2.08805224 |
| 133 | Sclerocornea (HP:0000647) | 2.08353883 |
| 134 | Muscle fibrillation (HP:0010546) | 2.07537408 |
| 135 | Respiratory failure (HP:0002878) | 2.06898977 |
| 136 | Vaginal atresia (HP:0000148) | 2.06759887 |
| 137 | Renal Fanconi syndrome (HP:0001994) | 2.06577103 |
| 138 | Facial cleft (HP:0002006) | 2.04906330 |
| 139 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.04644185 |
| 140 | Degeneration of anterior horn cells (HP:0002398) | 2.03683730 |
| 141 | Abnormality of the anterior horn cell (HP:0006802) | 2.03683730 |
| 142 | Muscle fiber atrophy (HP:0100295) | 2.03645421 |
| 143 | Abnormality of the musculature of the hand (HP:0001421) | 2.03300010 |
| 144 | Small intestinal stenosis (HP:0012848) | 2.03069059 |
| 145 | Duodenal stenosis (HP:0100867) | 2.03069059 |
| 146 | Sensory axonal neuropathy (HP:0003390) | 2.02788389 |
| 147 | Genital tract atresia (HP:0001827) | 2.02639679 |
| 148 | Abnormality of abdominal situs (HP:0011620) | 2.01559049 |
| 149 | Abdominal situs inversus (HP:0003363) | 2.01559049 |
| 150 | Renal duplication (HP:0000075) | 2.00517217 |
| 151 | Abnormal gallbladder morphology (HP:0012437) | 2.00453982 |
| 152 | Absent/shortened dynein arms (HP:0200106) | 1.99711249 |
| 153 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.99711249 |
| 154 | Cholelithiasis (HP:0001081) | 1.99521422 |
| 155 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.99455050 |
| 156 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.99455050 |
| 157 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.98489780 |
| 158 | Skin pits (HP:0100276) | 1.98348968 |
| 159 | Inability to walk (HP:0002540) | 1.98051619 |
| 160 | Progressive microcephaly (HP:0000253) | 1.97852951 |
| 161 | Abnormal trabecular bone morphology (HP:0100671) | 1.96773277 |
| 162 | Poor suck (HP:0002033) | 1.96386577 |
| 163 | Cerebral hypomyelination (HP:0006808) | 1.96028097 |
| 164 | Increased connective tissue (HP:0009025) | 1.95993278 |
| 165 | Postnatal microcephaly (HP:0005484) | 1.95472025 |
| 166 | Pseudobulbar signs (HP:0002200) | 1.94749097 |
| 167 | Combined immunodeficiency (HP:0005387) | 1.94611222 |
| 168 | Nasal polyposis (HP:0100582) | 1.93448090 |
| 169 | Diastasis recti (HP:0001540) | 1.92134292 |
| 170 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.91828120 |
| 171 | Delusions (HP:0000746) | 1.91136483 |
| 172 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 1.90509577 |
| 173 | Muscular hypotonia of the trunk (HP:0008936) | 1.90343209 |
| 174 | X-linked dominant inheritance (HP:0001423) | 1.90056330 |
| 175 | Medulloblastoma (HP:0002885) | 1.89755947 |
| 176 | Abnormality of the intrinsic pathway (HP:0010989) | 1.89742899 |
| 177 | Glossoptosis (HP:0000162) | 1.89449216 |
| 178 | Retinal atrophy (HP:0001105) | 1.89048671 |
| 179 | Amniotic constriction ring (HP:0009775) | 1.88722542 |
| 180 | Abnormality of placental membranes (HP:0011409) | 1.88722542 |
| 181 | Embryonal neoplasm (HP:0002898) | 1.88623390 |
| 182 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.87937654 |
| 183 | CNS hypomyelination (HP:0003429) | 1.87823320 |
| 184 | Progressive external ophthalmoplegia (HP:0000590) | 1.87238315 |
| 185 | Supernumerary nipples (HP:0002558) | 1.86154131 |
| 186 | Poor coordination (HP:0002370) | 1.83078063 |
| 187 | Aplastic anemia (HP:0001915) | 1.82961110 |
| 188 | Progressive neurologic deterioration (HP:0002344) | 1.77970301 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 8.49337898 |
| 2 | GRK5 | 5.58433196 |
| 3 | ERN1 | 4.57401718 |
| 4 | GRK6 | 4.47052428 |
| 5 | TESK1 | 3.76947030 |
| 6 | TRIM28 | 3.57032180 |
| 7 | ADRBK2 | 3.56458969 |
| 8 | PDK2 | 3.54105889 |
| 9 | BCKDK | 3.46740675 |
| 10 | PLK4 | 3.42947192 |
| 11 | GRK1 | 3.36055714 |
| 12 | LIMK1 | 2.87950417 |
| 13 | CSF1R | 2.79898655 |
| 14 | TTK | 2.60203339 |
| 15 | MUSK | 2.56712744 |
| 16 | TYRO3 | 2.52616793 |
| 17 | TGFBR2 | 2.49250056 |
| 18 | GRK7 | 2.39709869 |
| 19 | MAPK7 | 2.32899541 |
| 20 | PLK2 | 2.26109749 |
| 21 | STK10 | 2.19141006 |
| 22 | MOS | 2.17957218 |
| 23 | VRK2 | 2.10604505 |
| 24 | MATK | 2.04196498 |
| 25 | PBK | 2.01889275 |
| 26 | PIM2 | 2.00246063 |
| 27 | MAP4K2 | 1.93867011 |
| 28 | WNK1 | 1.92691136 |
| 29 | CSNK1G3 | 1.81706222 |
| 30 | AKT3 | 1.73474973 |
| 31 | ARAF | 1.61158798 |
| 32 | NME1 | 1.59099169 |
| 33 | CAMK4 | 1.57690125 |
| 34 | SRPK1 | 1.55563872 |
| 35 | CDK7 | 1.54998072 |
| 36 | NTRK1 | 1.47955449 |
| 37 | STK16 | 1.47699258 |
| 38 | CSNK1G1 | 1.42733662 |
| 39 | PRKG2 | 1.41621584 |
| 40 | ERBB3 | 1.39045351 |
| 41 | CSNK1A1L | 1.38337021 |
| 42 | CSNK1G2 | 1.34934587 |
| 43 | MAP3K4 | 1.33423066 |
| 44 | ZAK | 1.32787036 |
| 45 | MARK2 | 1.31018950 |
| 46 | DYRK3 | 1.25583326 |
| 47 | MAP2K7 | 1.25376827 |
| 48 | MAPK13 | 1.23692385 |
| 49 | CHEK2 | 1.19580624 |
| 50 | BRAF | 1.16078520 |
| 51 | HIPK2 | 1.16022777 |
| 52 | VRK1 | 1.15979305 |
| 53 | PLK3 | 1.15816967 |
| 54 | PAK4 | 1.14342220 |
| 55 | IRAK3 | 1.13187202 |
| 56 | TSSK6 | 1.11741520 |
| 57 | RAF1 | 1.11099344 |
| 58 | EPHA2 | 1.10607596 |
| 59 | ADRBK1 | 1.10537618 |
| 60 | PLK1 | 1.10311674 |
| 61 | MAP2K4 | 1.08086579 |
| 62 | FGFR3 | 1.07808274 |
| 63 | TLK1 | 1.04865111 |
| 64 | MAP3K10 | 1.03025283 |
| 65 | NME2 | 0.95790775 |
| 66 | MST4 | 0.95527029 |
| 67 | BCR | 0.88674586 |
| 68 | MST1R | 0.84973616 |
| 69 | MAP3K7 | 0.82463311 |
| 70 | BRSK1 | 0.82433686 |
| 71 | RPS6KA5 | 0.80568175 |
| 72 | LATS2 | 0.80149111 |
| 73 | CHEK1 | 0.78687900 |
| 74 | INSRR | 0.78262097 |
| 75 | MARK1 | 0.78029734 |
| 76 | ABL2 | 0.77533174 |
| 77 | EPHA4 | 0.76723230 |
| 78 | WEE1 | 0.76603748 |
| 79 | AKT2 | 0.74128448 |
| 80 | WNK3 | 0.73413139 |
| 81 | FER | 0.71601101 |
| 82 | NEK6 | 0.71071770 |
| 83 | ALK | 0.69440372 |
| 84 | NUAK1 | 0.69425114 |
| 85 | CDK14 | 0.69063596 |
| 86 | CASK | 0.68085507 |
| 87 | MAP2K6 | 0.67387997 |
| 88 | CAMK2G | 0.66518477 |
| 89 | CSK | 0.66018530 |
| 90 | EIF2AK2 | 0.65741173 |
| 91 | PRKCE | 0.64545058 |
| 92 | CDK19 | 0.61498902 |
| 93 | DAPK3 | 0.60345406 |
| 94 | MAPK12 | 0.59284288 |
| 95 | MAP3K8 | 0.56075230 |
| 96 | NEK2 | 0.55686626 |
| 97 | MTOR | 0.53703657 |
| 98 | TIE1 | 0.53229241 |
| 99 | DAPK1 | 0.52194652 |
| 100 | EIF2AK1 | 0.51572792 |
| 101 | CDC7 | 0.46720887 |
| 102 | CLK1 | 0.45359617 |
| 103 | ILK | 0.44756947 |
| 104 | PRKD3 | 0.44396200 |
| 105 | CDK2 | 0.43786431 |
| 106 | AURKA | 0.43378302 |
| 107 | CAMK2B | 0.42461280 |
| 108 | PHKG1 | 0.41831680 |
| 109 | PHKG2 | 0.41831680 |
| 110 | PTK2B | 0.41377655 |
| 111 | CAMK2D | 0.40746354 |
| 112 | PRPF4B | 0.40074010 |
| 113 | PKN1 | 0.39513879 |
| 114 | RPS6KB2 | 0.38646904 |
| 115 | MAPKAPK5 | 0.38223683 |
| 116 | ITK | 0.38183226 |
| 117 | ERBB4 | 0.37760326 |
| 118 | IGF1R | 0.37544939 |
| 119 | MAP3K9 | 0.37512871 |
| 120 | CDK8 | 0.37164677 |
| 121 | CAMK2A | 0.37051970 |
| 122 | WNK4 | 0.36122622 |
| 123 | ATM | 0.35800620 |
| 124 | CSNK2A1 | 0.35331258 |
| 125 | PTK2 | 0.35241045 |
| 126 | CDK4 | 0.34594355 |
| 127 | TAOK2 | 0.33999698 |
| 128 | BMPR1B | 0.33504674 |
| 129 | PRKD2 | 0.33341708 |
| 130 | PRKCD | 0.32816148 |
| 131 | PDGFRA | 0.31953047 |
| 132 | NEK1 | 0.31442228 |
| 133 | PRKCI | 0.30476787 |
| 134 | AURKB | 0.29337514 |
| 135 | RIPK1 | 0.28695981 |
| 136 | IKBKB | 0.26829364 |
| 137 | TNK2 | 0.26588928 |
| 138 | MAPKAPK3 | 0.25237601 |
| 139 | TAOK1 | 0.25107066 |
| 140 | CDK1 | 0.24887450 |
| 141 | MAPK10 | 0.24863580 |
| 142 | PRKAA1 | 0.24286511 |
| 143 | CSNK1E | 0.24210693 |
| 144 | INSR | 0.24185371 |
| 145 | PAK1 | 0.23722661 |
| 146 | BUB1 | 0.22869449 |
| 147 | BMX | 0.22222234 |
| 148 | ERBB2 | 0.20900974 |
| 149 | MAPK1 | 0.20661877 |
| 150 | PAK6 | 0.20353684 |
| 151 | STK38 | 0.20192940 |
| 152 | GSK3B | 0.19574724 |
| 153 | MAPK14 | 0.19174828 |
| 154 | CHUK | 0.18150472 |
| 155 | FLT3 | 0.16824477 |
| 156 | DYRK1A | 0.16440102 |
| 157 | PRKACG | 0.15525434 |
| 158 | ICK | 0.13289359 |
| 159 | SIK1 | 0.13174765 |
| 160 | PRKCG | 0.13066110 |
| 161 | TESK2 | 0.13059360 |
| 162 | PRKACB | 0.11136012 |
| 163 | CDK15 | 0.10808350 |
| 164 | AKT1 | 0.10307272 |
| 165 | PRKCH | 0.09762255 |
| 166 | CDK18 | 0.09209925 |
| 167 | ATR | 0.09000909 |
| 168 | PAK3 | 0.08911740 |
| 169 | CDK11A | 0.08495968 |
| 170 | RPS6KA3 | 0.07937038 |
| 171 | DYRK2 | 0.07871948 |
| 172 | MAPK4 | 0.07606353 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 6.50509625 |
| 2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 6.44248690 |
| 3 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 4.09115249 |
| 4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.95827924 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 3.39259650 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.28608976 |
| 7 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.80873359 |
| 8 | Galactose metabolism_Homo sapiens_hsa00052 | 2.76433542 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.68598500 |
| 10 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.46023960 |
| 11 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.28261325 |
| 12 | Parkinsons disease_Homo sapiens_hsa05012 | 2.24893110 |
| 13 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.14376592 |
| 14 | Huntingtons disease_Homo sapiens_hsa05016 | 2.07834716 |
| 15 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.03754678 |
| 16 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.99781902 |
| 17 | RNA polymerase_Homo sapiens_hsa03020 | 1.99239300 |
| 18 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.92261228 |
| 19 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.90353638 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.88439428 |
| 21 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.88329942 |
| 22 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.85843677 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.75849648 |
| 24 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.73417437 |
| 25 | Protein export_Homo sapiens_hsa03060 | 1.72806748 |
| 26 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.71701039 |
| 27 | RNA transport_Homo sapiens_hsa03013 | 1.69173278 |
| 28 | Thyroid cancer_Homo sapiens_hsa05216 | 1.68047278 |
| 29 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.67863372 |
| 30 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.67804223 |
| 31 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.63861921 |
| 32 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.63472777 |
| 33 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.62564881 |
| 34 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.55391234 |
| 35 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.54242242 |
| 36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.53664940 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51366028 |
| 38 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.49746621 |
| 39 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.45187947 |
| 40 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.43076788 |
| 41 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.42861132 |
| 42 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.42128992 |
| 43 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.38902717 |
| 44 | Alzheimers disease_Homo sapiens_hsa05010 | 1.37203214 |
| 45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.31734389 |
| 46 | Cell cycle_Homo sapiens_hsa04110 | 1.30623374 |
| 47 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.25144778 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.21336139 |
| 49 | Purine metabolism_Homo sapiens_hsa00230 | 1.17549605 |
| 50 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.15654225 |
| 51 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.14453231 |
| 52 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.13906246 |
| 53 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.12750374 |
| 54 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.12008284 |
| 55 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.11941477 |
| 56 | RNA degradation_Homo sapiens_hsa03018 | 1.10274888 |
| 57 | DNA replication_Homo sapiens_hsa03030 | 1.05946069 |
| 58 | Homologous recombination_Homo sapiens_hsa03440 | 1.05564633 |
| 59 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.99106031 |
| 60 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.98637633 |
| 61 | Mismatch repair_Homo sapiens_hsa03430 | 0.97722254 |
| 62 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.96581831 |
| 63 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.94509894 |
| 64 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.93544092 |
| 65 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.92942499 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.92691591 |
| 67 | Other glycan degradation_Homo sapiens_hsa00511 | 0.92362678 |
| 68 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.92260355 |
| 69 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.91336931 |
| 70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.91215366 |
| 71 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.90264391 |
| 72 | Peroxisome_Homo sapiens_hsa04146 | 0.88599387 |
| 73 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.87414932 |
| 74 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.84917941 |
| 75 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.82957664 |
| 76 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.82839796 |
| 77 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.80856850 |
| 78 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80787857 |
| 79 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.78429290 |
| 80 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.77134984 |
| 81 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.76705702 |
| 82 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.76530545 |
| 83 | Base excision repair_Homo sapiens_hsa03410 | 0.76079281 |
| 84 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.73029604 |
| 85 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.72711684 |
| 86 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.72681065 |
| 87 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.71150712 |
| 88 | Pathways in cancer_Homo sapiens_hsa05200 | 0.69105596 |
| 89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.68580559 |
| 90 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.67586299 |
| 91 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.67456372 |
| 92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66783014 |
| 93 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.65175848 |
| 94 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.64756852 |
| 95 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.63426922 |
| 96 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.61604077 |
| 97 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61591690 |
| 98 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.61459064 |
| 99 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.61034456 |
| 100 | Bladder cancer_Homo sapiens_hsa05219 | 0.60046947 |
| 101 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.59986712 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58956274 |
| 103 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.58748239 |
| 104 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58489830 |
| 105 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.58118078 |
| 106 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.56604917 |
| 107 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.56125374 |
| 108 | Spliceosome_Homo sapiens_hsa03040 | 0.54873009 |
| 109 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.53484826 |
| 110 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.53120580 |
| 111 | Basal transcription factors_Homo sapiens_hsa03022 | 0.51592281 |
| 112 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.51111724 |
| 113 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.49926166 |
| 114 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.49835239 |
| 115 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48323576 |
| 116 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.47745168 |
| 117 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.47281870 |
| 118 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.45802827 |
| 119 | Carbon metabolism_Homo sapiens_hsa01200 | 0.45451484 |
| 120 | Sulfur relay system_Homo sapiens_hsa04122 | 0.45249366 |
| 121 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.45210398 |
| 122 | Apoptosis_Homo sapiens_hsa04210 | 0.44073508 |
| 123 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.43354098 |
| 124 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.43261702 |
| 125 | Taste transduction_Homo sapiens_hsa04742 | 0.42585240 |
| 126 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.39693248 |
| 127 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.39283423 |
| 128 | Colorectal cancer_Homo sapiens_hsa05210 | 0.38624893 |
| 129 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38113910 |
| 130 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.37473083 |
| 131 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.36997095 |
| 132 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.36793272 |
| 133 | Phototransduction_Homo sapiens_hsa04744 | 0.35920552 |
| 134 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.35736063 |
| 135 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.35199885 |
| 136 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.34002646 |
| 137 | HTLV-I infection_Homo sapiens_hsa05166 | 0.33473078 |
| 138 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.33416713 |
| 139 | Alcoholism_Homo sapiens_hsa05034 | 0.33281748 |
| 140 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32961186 |
| 141 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.31042307 |
| 142 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.30838250 |
| 143 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.29194175 |
| 144 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.28664011 |
| 145 | Adherens junction_Homo sapiens_hsa04520 | 0.28578024 |
| 146 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.27818590 |
| 147 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.27291119 |
| 148 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.26601749 |
| 149 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.25542447 |
| 150 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.25477495 |
| 151 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.24022056 |
| 152 | Olfactory transduction_Homo sapiens_hsa04740 | 0.23842853 |
| 153 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.23799777 |
| 154 | Lysosome_Homo sapiens_hsa04142 | 0.22020735 |
| 155 | Lysine degradation_Homo sapiens_hsa00310 | 0.20644584 |
| 156 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.19477502 |
| 157 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.19075831 |
| 158 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.16624067 |
| 159 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.16601355 |
| 160 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.16051750 |
| 161 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.16016256 |
| 162 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.15654921 |

